Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/15/2019 4:30:58 PM - Followers: 78 - Board type: Free - Posts Today: 0

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2098   When will the Next Big R/S kick in Value_Investor 03/15/19 04:30:58 PM
#2097   I have to read the proxy, just received Chimer57 03/06/19 07:06:59 AM
#2096   When's the next R/S kicking in because i'm Wuoltk 03/06/19 07:01:51 AM
#2095   Here we go, another R/S I was Chimer57 03/06/19 06:43:36 AM
#2094   Anyone holding NSPR/WS (NSPR+)? These warrants are very thin. Wuoltk 02/22/19 04:26:21 PM
#2093   Bloodbath next week. Good luck to you guys 420man 02/08/19 07:27:59 PM
#2092   Agreed!! 420man 02/08/19 06:43:55 PM
#2091   Oh my... I just now saw the news! 420man 02/08/19 06:39:55 PM
#2090   Actually went down to .14 AH. I think 420man 02/08/19 06:37:12 PM
#2089   Say HE'LL NO to all of the proposals, Three2001 02/08/19 06:16:35 PM
#2088   Why NSPR crashed to $0.185 today? Value_Investor 02/08/19 04:59:41 PM
#2087   * * $NSPR Video Chart 02-07-2019 * * ClayTrader 02/07/19 05:37:01 PM
#2086   So.... The main Doctor gets his 400K yearly 420man 02/06/19 07:46:04 PM
#2085   At least an insider is picking up cheap Three2001 02/05/19 04:58:26 PM
#2084   I'm lowering my selling target area to $0.19 Value_Investor 02/01/19 03:13:08 PM
#2083   at this point, yes - great news for finesand 01/31/19 08:31:53 PM
#2082   I could write a lengthy and detailed reponse 420man 01/31/19 05:15:37 PM
#2081   Should Another Big R/S kick in how low Value_Investor 01/31/19 01:33:05 PM
#2080   Unfortunately, the only ones to blame if that 420man 01/30/19 07:41:24 PM
#2079   I'm more concerning about the coming inevitable Big Value_Investor 01/30/19 07:32:27 PM
#2078   Because it's a POS! :( 420man 01/29/19 01:37:11 PM
#2077   Why NSPR crashed to $0.17 again this early Value_Investor 01/29/19 01:29:38 PM
#2076   Sadly....this one is over in my opinion unless 420man 01/29/19 10:52:45 AM
#2075   Why NSPR crash to $0.17 so far? Any Value_Investor 01/28/19 09:59:08 AM
#2074   NSPR diluted way too much and now thinks 420man 01/24/19 12:53:49 PM
#2073   https://linc2019.cncptdlx.com/media/1515_Pavel_Ignatenko_22_01_2019_Room_6_-_Spe Jim88888 01/23/19 03:35:13 PM
#2072   https://linc2019.cncptdlx.com/media/1515_Pavel_Ignatenko_22_01_2019_Room_6_-_Spe Jim88888 01/23/19 03:35:05 PM
#2071   https://linc2019.cncptdlx.com/media/1515_Pavel_Ignatenko_22_01_2019_Room_6_-_Spe Jim88888 01/23/19 03:34:20 PM
#2070   Could this FDA warning actually help with the Three2001 01/22/19 05:24:08 PM
#2069   I think they have time until july 7, jarubr 01/22/19 02:01:55 PM
#2068   I really do not know what else has jarubr 01/22/19 01:32:17 PM
#2067   When will the company do the next Big Value_Investor 01/22/19 11:45:56 AM
#2066   I've got my fingers crossed jarubr 01/21/19 03:53:18 AM
#2065   Nail on the head...they trade on an U.S. 420man 01/18/19 09:19:35 PM
#2064   Amazing how it seems to move every time Three2001 01/18/19 08:09:06 PM
#2063   Decent move up today, but they will have 420man 01/18/19 06:19:18 PM
#2062   * * $NSPR Video Chart 01-18-2019 * * ClayTrader 01/18/19 04:39:35 PM
#2061   NSPR HAS to substantially improve their share price, 420man 01/17/19 05:26:43 PM
#2060   Sabby still shorting, in w/ 1.8M shares finesand 01/17/19 06:00:50 AM
#2059   on NYSE MKT (or American) min bid is finesand 01/17/19 05:36:12 AM
#2058   Because it is a shady company in my tomsen 01/16/19 12:45:13 PM
#2057   Quick question for all: why good or very Value_Investor 01/16/19 11:02:15 AM
#2056   Well it wasn't the SEC but rather the tomsen 01/15/19 02:31:17 PM
#2055   I don't want to assume or guess at tomsen 01/15/19 11:35:37 AM
#2054   NSPR has Great News today --- see the Value_Investor 01/14/19 09:20:39 AM
#2053   To those reading...NSPR used Sabby as an lender, 420man 01/13/19 04:44:54 PM
#2052   As expected... 420man 01/11/19 07:15:51 PM
#2051   If this continues to trade under .20 until 420man 01/08/19 08:15:23 PM
#2050   It is truly amazing how much crap this tomsen 01/04/19 11:54:40 AM
#2049   Same junk happened last year. Stock went tomsen 01/02/19 01:55:51 PM
PostSubject